AWKN Stock Overview
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe.
Awakn Life Sciences Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.17|
|52 Week High||CA$0.77|
|52 Week Low||CA$0.055|
|1 Month Change||-7.89%|
|3 Month Change||-37.50%|
|1 Year Change||-43.55%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-91.97%|
Recent News & Updates
|AWKN||CA Biotechs||CA Market|
Return vs Industry: AWKN underperformed the Canadian Biotechs industry which returned 19% over the past year.
Return vs Market: AWKN underperformed the Canadian Market which returned -1.2% over the past year.
|AWKN Average Weekly Movement||46.2%|
|Biotechs Industry Average Movement||12.3%|
|Market Average Movement||8.8%|
|10% most volatile stocks in CA Market||17.9%|
|10% least volatile stocks in CA Market||3.5%|
Stable Share Price: AWKN is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 46% a week.
Volatility Over Time: AWKN's weekly volatility has increased from 30% to 46% over the past year.
About the Company
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.
Awakn Life Sciences Corp. Fundamentals Summary
|AWKN fundamental statistics|
Is AWKN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AWKN income statement (TTM)|
|Cost of Revenue||CA$3.05m|
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
|Earnings per share (EPS)||-0.20|
|Net Profit Margin||-491.55%|
How did AWKN perform over the long term?See historical performance and comparison